Potassium canrenoate structure
|
Common Name | Potassium canrenoate | ||
---|---|---|---|---|
CAS Number | 2181-04-6 | Molecular Weight | 396.56200 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H29KO4 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Potassium canrenoateCanrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor) antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3]. |
Name | Canrenoic Acid Potassium Salt |
---|---|
Synonym | More Synonyms |
Description | Canrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor) antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3]. |
---|---|
Related Catalog | |
In Vivo | Potassium canrenoate has been shown to cause in rats a dose-dependent increase in myelogenous leukemia and statistically significant increases in malignant tumor of the liver, thyroid, brain and mammary gland[2][3]. Potassium canrenoate (20 mg/kg/day; drinking water) reduces isoprenaline-induced cardiac fibrosis in the rat[4]. |
References |
Molecular Formula | C22H29KO4 |
---|---|
Molecular Weight | 396.56200 |
Exact Mass | 396.17000 |
PSA | 77.43000 |
LogP | 2.55550 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R22 |
Safety Phrases | S36 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | TU3500000 |
HS Code | 2916209090 |
HS Code | 2916209090 |
---|---|
Summary | 2916209090 other cyclanic, cyclenic or cyclotherpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
Effect of the steroid K-canrenoate on hsp70 expression and tissue damage in transgenic Drosophila melanogaster (hsp70-lacZ) Bg9.
J. Insect Sci. 12 , 92, (2012) In the present study the effect of 0.1, 0.2, 0.4, 0.8, and 1.0 µL/mL of the steroid K-canrenoate was evaluated in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ) Bg(9) for 6... |
|
Mineralocorticoids participate in the reduced vascular reactivity of pregnant rats.
Am. J. Physiol. Heart Circ. Physiol. 302(5) , H1195-201, (2012) The renin-angiotensin-aldosterone (RAA) system is markedly activated in pregnancy. We evaluated if mineralocorticoid receptors (MR), a major component of the RAA system, are involved in the reduced va... |
|
Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice.
FASEB J. 28(6) , 2430-40, (2014) Studies have shown that aldosterone would have angiogenic effects and therefore would be beneficial in the context of cardiovascular diseases. We thus investigated the potential involvement of aldoste... |
Potassium canrenoate |
Canrenoic acid potassium salt |
17-Hydroxy-3-oxopregna-4,6-diene-21-carboxylic acid,Potassium canrenoate |
MFCD05662375 |
EINECS 218-554-9 |